RESULTS: Incubation in vitro of human recombinant and erythrocyte (RBC) thiopurine methyl transferase (TPMT) with furosemide, bendroflumethiazide and trichlormethiazide demonstrated inhibition of both enzyme preparations, with IC50 values of 170 microM, 360 microM and 1 mM, respectively. Kinetic studies revealed that the inhibition was mixed or non-competitive with regard both to the thiopurine substrate 6-mercaptopurine (6-MP) and the methyl donor S-adenosyl-L-methionine. CONCLUSION: Since S-methylation is a major pathway in the metabolism of thiopurines, our data point to the possibility of a clinically significant diuretic-thiopurine interaction in patients treated simultaneously with these drugs.
RESULTS: Incubation in vitro of human recombinant and erythrocyte (RBC) thiopurine methyl transferase (TPMT) with furosemide, bendroflumethiazide and trichlormethiazide demonstrated inhibition of both enzyme preparations, with IC50 values of 170 microM, 360 microM and 1 mM, respectively. Kinetic studies revealed that the inhibition was mixed or non-competitive with regard both to the thiopurine substrate 6-mercaptopurine (6-MP) and the methyl donorS-adenosyl-L-methionine. CONCLUSION: Since S-methylation is a major pathway in the metabolism of thiopurines, our data point to the possibility of a clinically significant diuretic-thiopurine interaction in patients treated simultaneously with these drugs.
Authors: J J Van Meyel; P G Gerlag; P Smits; F G Russel; Y Tan; C A Van Ginneken; F W Gribnau Journal: Clin Pharmacokinet Date: 1992-04 Impact factor: 6.447
Authors: R Honchel; I A Aksoy; C Szumlanski; T C Wood; D M Otterness; E D Wieben; R M Weinshilboum Journal: Mol Pharmacol Date: 1993-06 Impact factor: 4.436
Authors: T Dervieux; Y Médard; V Baudouin; A Maisin; D Zhang; F Broly; C Loirat; E Jacqz-Aigrain Journal: Br J Clin Pharmacol Date: 1999-12 Impact factor: 4.335
Authors: Andres J Yarur; Maria T Abreu; Amar R Deshpande; David H Kerman; Daniel A Sussman Journal: World J Gastroenterol Date: 2014-04-07 Impact factor: 5.742
Authors: Barbara Wusk; G A Kullak-Ublick; C Rammert; A von Eckardstein; M Fried; K M Rentsch Journal: Eur J Clin Pharmacol Date: 2004-02-24 Impact factor: 2.953